TotalMarketCap

Madrigal Pharmaceuticals

MDGLNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$11.019 B

$476.91 -2.22%

Close of 9 Oct 2026

As of 9 Oct 2026, Madrigal Pharmaceuticals (MDGL) has a market capitalization of $11.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$180.1M

#2313 by revenue

Earnings

-$288.3M

Loss-making

Shares outstanding

23,104,126

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #29BridgeBio PharmaBBIO$12.7B
  2. #30Elanco Animal HealthELAN$11.3B
  3. #31Madrigal PharmaceuticalsMDGL$11.0B
  4. #32Biomarin PharmaceuticalBMRN$10.6B
  5. #33Dr Reddys LaboratoriesRDY$10.2B

What if Madrigal Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $29.1T

$1,257,864

Per share 2,638× higher

Bitcoin $1.66T

$71,873.75

Per share 151× higher

Nvidia $5.55T

$240,414.55

Per share 504× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Madrigal Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.